These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7978795)

  • 1. Matrix metalloproteinases and their inhibitors in tumor progression.
    De Clerck YA; Shimada H; Taylor SM; Langley KE
    Ann N Y Acad Sci; 1994 Sep; 732():222-32. PubMed ID: 7978795
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of matrix metalloproteinase activity.
    Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
    Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
    [No Abstract]   [Full Text] [Related]  

  • 3. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
    Hewitt R; Danø K
    Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.
    Khokha R; Denhardt DT
    Invasion Metastasis; 1989; 9(6):391-405. PubMed ID: 2689386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinases in tumor cells].
    Seiki M
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):387-92. PubMed ID: 8439185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix metalloproteinases in tumor invasion and metastasis.
    Goldberg GI; Eisen AZ
    Cancer Treat Res; 1991; 53():421-40. PubMed ID: 1672089
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteolytic remodeling of extracellular matrix.
    Birkedal-Hansen H
    Curr Opin Cell Biol; 1995 Oct; 7(5):728-35. PubMed ID: 8573349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases: a review.
    Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
    Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and cardiovascular disease.
    Dollery CM; McEwan JR; Henney AM
    Circ Res; 1995 Nov; 77(5):863-8. PubMed ID: 7554139
    [No Abstract]   [Full Text] [Related]  

  • 12. Matrix metalloproteinases and their inhibitors.
    Murphy G
    Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue inhibitors of matrix metalloproteinases in cancer.
    Blavier L; Henriet P; Imren S; Declerck YA
    Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural biochemistry and activation of matrix metalloproteases.
    Kleiner DE; Stetler-Stevenson WG
    Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM; Fridman R
    Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitors of metalloproteinases: role in tumor progression.
    De Clerck YA; Alvarez O; Shimada H; Taylor SM; Langley KE
    Contrib Nephrol; 1994; 107():108-15. PubMed ID: 8004956
    [No Abstract]   [Full Text] [Related]  

  • 17. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.